Detalhe da pesquisa
1.
DNA prime/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant.
J Gen Virol
; 98(8): 2143-2155, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28758637
2.
Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge.
PLoS Pathog
; 11(8): e1005101, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26267144
3.
Antigenicity and immunogenicity of a trimeric envelope protein from an Indian clade C HIV-1 isolate.
J Biol Chem
; 290(14): 9195-208, 2015 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25691567
4.
Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques.
J Virol
; 86(23): 12591-604, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22973034
5.
Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challenge.
J Virol
; 86(8): 4644-57, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22345466
6.
Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults.
Nat Commun
; 14(1): 1138, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878897
7.
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates.
iScience
; 24(2): 102047, 2021 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33554060
8.
Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge.
J Virol
; 82(21): 10911-21, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18753198
9.
Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques.
Virology
; 440(2): 210-21, 2013 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23528732
10.
Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge.
Virology
; 411(1): 87-102, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21237474
11.
Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strains.
Vaccine
; 28(23): 3963-71, 2010 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-20382241
12.
Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques.
Virology
; 374(2): 322-37, 2008 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18252262
13.
A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
J Virol
; 81(7): 3414-27, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17229693
14.
Subunit recombinant vaccine protects against monkeypox.
J Immunol
; 177(4): 2552-64, 2006 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16888017